Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis
Abstract Background Sepsis-caused multi-organ failure remains the major cause of morbidity and mortality in intensive care units with limited therapeutics. Nicotinamide mononucleotide (NMN), a precursor of nicotinamide adenine dinucleotide (NAD+), has been recently reported to be protective in sepsi...
| Published in: | Journal of Translational Medicine |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-12-01
|
| Online Access: | https://doi.org/10.1186/s12967-023-04767-3 |